128 related articles for article (PubMed ID: 37747447)
21. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
[No Abstract] [Full Text] [Related]
22. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
[TBL] [Abstract][Full Text] [Related]
23. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
[TBL] [Abstract][Full Text] [Related]
24. CLINICAL IMPACT OF NON-INVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES ON THE RISK OF MALIGNANCY IN THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A META-ANALYSIS OF 14,153 RESECTED THYROID NODULES.
Vuong HG; Tran TTK; Bychkov A; Jung CK; Nakazawa T; Kakudo K; Katoh R; Kondo T
Endocr Pract; 2019 May; 25(5):491-502. PubMed ID: 30657357
[No Abstract] [Full Text] [Related]
25. Comparison of core-needle biopsy and repeat fine-needle aspiration for thyroid nodules with inconclusive initial cytology.
Jung SM; Koo HR; Jang KS; Chung MS; Song CM; Ji YB; Park JS; Tae K
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3019-3025. PubMed ID: 33196875
[TBL] [Abstract][Full Text] [Related]
26. The combination of ACR-Thyroid Imaging Reporting and Data system and The Bethesda System for Reporting Thyroid Cytopathology in the evaluation of thyroid nodules-An institutional experience.
Sakthisankari S; Vidhyalakshmi S; Shanthakumari S; Devanand B; Nagul U
Cytopathology; 2021 Jul; 32(4):472-481. PubMed ID: 33606346
[TBL] [Abstract][Full Text] [Related]
27. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
[TBL] [Abstract][Full Text] [Related]
28. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
Choden S; Wangmo C; Maharjan S
Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
[TBL] [Abstract][Full Text] [Related]
29. Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy?
Srbova L; Gabalec F; Ryska A; Cap J
Cytopathology; 2015 Aug; 26(4):231-7. PubMed ID: 25077794
[TBL] [Abstract][Full Text] [Related]
30. Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories.
Guerreiro SC; Tastekin E; Mourao M; Loureiro I; Eusebio R; Marques HP; Oznur M; Caliskan CK; Schmitt FC; Bongiovanni M; Canberk S
Acta Cytol; 2023; 67(6):593-603. PubMed ID: 37899024
[TBL] [Abstract][Full Text] [Related]
31. A Large Thyroid Fine Needle Aspiration Biopsy Cohort with Long-Term Population-Based Follow-Up.
Ng DL; van Zante A; Griffin A; Hills NK; Ljung BM
Thyroid; 2021 Jul; 31(7):1086-1095. PubMed ID: 33371796
[No Abstract] [Full Text] [Related]
32. Ultrasound Parameters of Thyroid Nodules and the Risk of Malignancy: A Retrospective Analysis.
Wang M; Sun P; Zhao X; Sun Y
Cancer Control; 2020; 27(1):1073274820945976. PubMed ID: 33035078
[TBL] [Abstract][Full Text] [Related]
33. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison.
Al-Salam S; Sharma C; Abu Sa'a MT; Afandi B; Aldahmani KM; Al Dhaheri A; Yahya H; Al Naqbi D; Al Zuraiqi E; Mohamed BK; Almansoori SA; Al Zaabi M; Al Derei A; Al Shamsi A; Kaabi JA
PLoS One; 2021; 16(4):e0247807. PubMed ID: 33826647
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of cell block in fine needle aspiration cytology of thyroid gland.
Vance J; Durbin K; Manglik N; Gilani SM
Diagn Cytopathol; 2019 Dec; 47(12):1245-1250. PubMed ID: 31411821
[TBL] [Abstract][Full Text] [Related]
36. Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation.
Mastorakis E; Meristoudis C; Margari N; Pouliakis A; Leventakos K; Chroniaris N; Panayiotides I; Karakitsos P
Cytopathology; 2014 Apr; 25(2):120-8. PubMed ID: 23551656
[TBL] [Abstract][Full Text] [Related]
37. Degenerative atypia in benign thyroid nodules: a potential diagnostic pitfall on fine-needle aspiration.
Lam H; Saoud C; Shi Q; Wong KS; Cibas ES; Rooper LM; Baloch Z; Ali SZ
J Am Soc Cytopathol; 2023; 12(5):341-350. PubMed ID: 37230891
[TBL] [Abstract][Full Text] [Related]
38. Optimal timing for a repeat fine-needle aspiration biopsy of thyroid nodule following an initial nondiagnostic fine-needle aspiration.
Deniwar A; Hammad AY; Ali DB; Alsaleh N; Lahlouh M; Sholl AB; Moroz K; Aslam R; Thethi T; Kandil E
Am J Surg; 2017 Feb; 213(2):433-437. PubMed ID: 27475222
[TBL] [Abstract][Full Text] [Related]
39. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
40. A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience.
Arul P; Akshatha C; Masilamani S
Biomed J; 2015 Dec; 38(6):517-22. PubMed ID: 27013451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
